A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
for Advanced Non-small Cell Lung Cancer, HER2 Mutation
27 locations incl. Newport Beach
Sponsor: Bayer
Sex: All·Age: 18+
Code: NCT06452277·Phase 3·Recruiting